333

UNIVERSAL VISION BIOTECHNOLOGY CO

No trades
See on Supercharts

3218 fundamentals

UNIVERSAL VISION BIOTECHNOLOGY CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 3218 for the last quarter is 992.88 M TWD, and it's 6.47% lower compared to the previous quarter. The net income of Q4 23 is 253.14 M TWD.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: TWD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth